Cetero Research, the leading early-stage contract research organization (CRO), today announced it has completed more than 500 diabetes research studies in the past three years for both Type 1 and Type 2 diabetics, including complex clamp studies and studies in Phase I, II, III and IV. Cetero is the only CRO that can combine both pivotal pharmacokinetic studies and proof-of-concept studies in one study, saving up to six months of development time.
Ampio Pharmaceuticals, Inc. announced today the signing of a contract with St. Michael's Hospital, Toronto, Canada to conduct, "A Randomized, Placebo-Controlled, Parallel Treatment Group, Double-Masked Study to Evaluate the Efficacy and Safety of Three Doses of Oral OptinaTM in Adult Subjects with Diabetic Macular Edema". This phase II trial will seek the optimal content of each dose using industry standard methods of Optical Coherence Tomography (OCT) and Best Corrected Visual Acuity (BCVA). The data will be used to construct a pivotal phase III trial for submission to regulatory bodies in the USA, Europe and Asia.
With diabetes affecting the lives of millions of people throughout the Midwest, Meijer announced plans today to begin offering Metformin Immediate Release, the most commonly prescribed treatment for type 2 diabetes, at no cost to those with a medical prescription. Meijer's program will include doses prescribed in 500mg, 850mg and 1000mg tablets.
The Illinois Nurses Association, which has fought for patient safety for more than a century, is helping to lead the fight against HB 6065/SB 3822, legislation that could endanger all school children, especially children with diabetes.
Many moms find themselves balancing on that tricky tightrope between providing their family healthy meals and managing their family's hectic day-to-day schedule. With obesity, pre-diabetes and type 2 diabetes on a dramatic rise, it is more important than ever to do both. This Mother's Day, the American Diabetes Association offers easy-to-do tips so busy moms strike that balance.
Pittsburgh is treating diabetes more cost effectively than the rest of the state and nation, and its efforts to help people better manage their disease are paying dividends. Still, a gap exists between the region and the nation's top performers, according to the third annual Pittsburgh Business Group on Health Type 2 Diabetes Report.
A new international gene study has discovered two gene variants on chromosome 3 that predispose babies to having a lower birth weight. The genes also are linked to the development of type 2 diabetes later in life, based on research by the Early Growth Genetics Consortium on DNA from more than 10,000 individuals in three European countries. Dr. Mark McCarthy, of the Wellcome Trust Centre for Human Genetics at the University of Oxford in the U.K., led the study, published today in Nature Genetics.
The Diabetes Research Institute Foundation announced today that its largest contributor, the Building and Construction Trades Department (BCTD) of the AFL-CIO, has pledged $5 million to be awarded over five years. This new gift brings the total dollars raised to more than $45 million over the last 25 years and firmly cements the unions' commitment to help the Diabetes Research Institute (DRI) find a cure for diabetes.
MinuteClinic, the largest provider of retail-based medical clinics in the United States, has introduced a series of convenient health condition monitoring services to help patients previously diagnosed with diabetes, asthma, high cholesterol and high blood pressure overcome the challenges of living with their conditions. Health condition monitoring is available at MinuteClinic locations in CVS/pharmacy stores in 20 states and the District of Columbia. MinuteClinic is the retail health care division of CVS Caremark.
Diabetes patients had higher rates of medication adherence and lower general medical costs after switching to mail delivery of their prescriptions for at least 12 months, according to results of a study released today by Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America.